International Biotechnology Trust PLC Bluebird Bio, Inc. Transaction History

International Biotechnology Trust PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$8.96 - $16.31 $98,560 - $179,410	-11,000 Closed	0 $0
Q1 2020 May 18, 2020	SELL	$26.16 - $63.5 $156,960 - $381,000	-6,000 Reduced 35.29%	11,000 $505,000
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $5.33 Million - $7.05 Million	-60,000 Reduced 77.92%	17,000 $1.9 Million
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $5.07 Million - $6.7 Million	57,000 Added 285.0%	77,000 $2.29 Million
Q3 2017 Mar 02, 2018	BUY	$57.74 - $91.42 $1.15 Million - $1.83 Million	20,000	20,000 $2.75 Million

150

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $670M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.